Next Article in Journal
Mesenchymal Stem Cell Derived Biocompatible Membrane Vesicles Demonstrate Immunomodulatory Activity Inhibiting Activation and Proliferation of Human Mononuclear Cells
Next Article in Special Issue
Like a Rolling Stone: Sting-Cgas Pathway and Cell-Free DNA as Biomarkers for Combinatorial Immunotherapy
Previous Article in Journal
RGD-PEG-PLA Delivers MiR-133 to Infarct Lesions of Acute Myocardial Infarction Model Rats for Cardiac Protection
Previous Article in Special Issue
Tumor-Homing pH-Sensitive Extracellular Vesicles for Targeting Heterogeneous Tumors
Article

Phage Display-Based Homing Peptide-Daunomycin Conjugates for Selective Drug Targeting to PANC-1 Pancreatic Cancer

1
MTA-ELTE Research Group of Peptide Chemistry, Hungarian Academy of Sciences, 1117 Budapest, Hungary
2
Institute of Chemistry, Faculty of Sciences, Eötvös Loránd University, 1117 Budapest, Hungary
3
Department of Genetics, Cell- and Immunobiology, Semmelweis University, 1089 Budapest, Hungary
4
National Institute of Oncology, Department of Experimental Pharmacology, 1122 Budapest, Hungary
*
Author to whom correspondence should be addressed.
Pharmaceutics 2020, 12(6), 576; https://doi.org/10.3390/pharmaceutics12060576
Received: 20 May 2020 / Revised: 11 June 2020 / Accepted: 17 June 2020 / Published: 22 June 2020
(This article belongs to the Special Issue Novel Anticancer Strategies)
The Pancreatic Ductal Adenocarcinoma (PDAC) is one of the most aggressive and dangerous cancerous diseases, leading to a high rate of mortality. Therefore, the development of new, more efficient treatment approaches is necessary to cure this illness. Peptide-based drug targeting provides a new tool for this purpose. Previously, a hexapeptide Cys-Lys-Ala-Ala-Lys-Asn (CKAAKN) was applied efficiently as the homing device for drug-loaded nanostructures in PDAC cells. In this research, Cys was replaced by Ser in the sequence and this new SKAAKN targeting moiety was used in conjugates containing daunomycin (Dau). Five different structures were developed and tested. The results indicated that linear versions with one Dau were not effective on PANC-1 cells in vitro; however, branched conjugates with two Dau molecules showed significant antitumor activity. Differences in the antitumor effect of the conjugates could be explained with the different cellular uptake and lysosomal degradation. The most efficient conjugate was Dau=Aoa-GFLG-K(Dau=Aoa)SKAAKN-OH (conjugate 4) that also showed significant tumor growth inhibition on s.c. implanted PANC-1 tumor-bearing mice with negligible side effects. Our novel results suggest that peptide-based drug delivery systems could be a promising tool for the treatment of pancreatic cancers. View Full-Text
Keywords: pancreatic cancer; targeted tumor therapy; homing peptide; antitumor peptide conjugates; daunomycin; oxime linkage pancreatic cancer; targeted tumor therapy; homing peptide; antitumor peptide conjugates; daunomycin; oxime linkage
Show Figures

Graphical abstract

MDPI and ACS Style

Dókus, L.E.; Lajkó, E.; Ranđelović, I.; Mező, D.; Schlosser, G.; Kőhidai, L.; Tóvári, J.; Mező, G. Phage Display-Based Homing Peptide-Daunomycin Conjugates for Selective Drug Targeting to PANC-1 Pancreatic Cancer. Pharmaceutics 2020, 12, 576. https://doi.org/10.3390/pharmaceutics12060576

AMA Style

Dókus LE, Lajkó E, Ranđelović I, Mező D, Schlosser G, Kőhidai L, Tóvári J, Mező G. Phage Display-Based Homing Peptide-Daunomycin Conjugates for Selective Drug Targeting to PANC-1 Pancreatic Cancer. Pharmaceutics. 2020; 12(6):576. https://doi.org/10.3390/pharmaceutics12060576

Chicago/Turabian Style

Dókus, Levente E., Eszter Lajkó, Ivan Ranđelović, Diána Mező, Gitta Schlosser, László Kőhidai, József Tóvári, and Gábor Mező. 2020. "Phage Display-Based Homing Peptide-Daunomycin Conjugates for Selective Drug Targeting to PANC-1 Pancreatic Cancer" Pharmaceutics 12, no. 6: 576. https://doi.org/10.3390/pharmaceutics12060576

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop